Several documents for the B- and C-points on the agenda of the SCoPAFF Legislation meeting of 24-25 March 2021 were uploaded to the Comitology Register.
The agenda for the upcoming SCoPAFF Legislation meeting was published on the Commission website.
On 04.03.2021 DG SANTE published the short report on the SCoPAFF Legislation meeting of 22-23.10.2020.
On 05.02.2021 the Polish competent authority published its report on the SCoPAFF Legislation meeting of 03-04.12.2020.
On 06.01.2021, the agenda for the upcoming SCoPAFF Legislation meeting of 25-26.01.2021 was published.
On 16.11.2020 the agenda for the SCoPAFF Legislation meeting of 3-4 December was published.
The agenda for the SCoPAFF Legislation meeting of 22-23.10.2020 was published on 06.10.2020
EFSA published a conclusion on the peer review of captan.
captan, chlorantraniliprole, quinmerac, Trichoderma atroviride strain I-1237
On 29.07.2020 the minutes of the SCoPAFF Legislation meeting of 18-19 May were published.
aclonifen, aminopyralid, Beauveria bassiana strain 203, bentazone, captan, carbon dioxide, difenoconazole, dodine, fludioxonil, flutriafol, glyphosate, Pepino mosaic virus CH2 strain mild isolate...
on 25.06.2020 a Regulation was published, extending the approval periods of 26 substances.
The European Parliament published the draft agenda for the next plenary meeting.
On the agenda of the meeting of 8 June 2020 of the ENVI Committee appears another objection against the extension of substances.
The voting results of the SCoPAFF Legislation meeting of 18-19 May 2020 are known.
Changes in the EFSA Register of Questions on 19.05.2020
On 30.04.2020 DG SANTE published the agenda for the SCoPAFF Legislation meeting of 18-19 May 2020.
On 10.10.2019 the European Parliament has adopted its resolution on Draft Commission Regulation amending Implementing Regulation (EU) 540/2011 as regards the extension of the approval periods...
On 01.10.2019 the European Parliament issued a motion for a resolution on Regulation 2019/707 of 7 May 2019 on the extension of the approval periods of flumioxazine and 33 other substances.